Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 21, 2026Journal of Psychopharmacology

Roland R. Griffiths, psychopharmacology pioneer: Abuse liability, alcohol, nicotine, caffeine, benzodiazepines, and psychedelics

View Full Paper
Ask AI
Bookmark
Share

Authors

JHJack E. HenningfieldFBFrederick S. BarrettSESuzette M. Evans

Discussion

Loading...

Member takes

Overview

This review highlights contributions to psychopharmacology and research partnerships fostering effective collaboration.

Key Points

  • The review aims to summarize Roland R. Griffiths' impactful research and collaborative approach in psychopharmacology.
  • Overview of Griffiths’ research domains including alcohol, nicotine, benzodiazepines, and psychedelics.
  • Personal anecdotes and insights from mentees and collaborators.
  • Assessment of preclinical and clinical abuse liability methodologies.
  • Griffiths' work transformed understanding of abuse liability across various substances.
  • His collaborative approach fostered innovation and research productivity.
  • The establishment of the Johns Hopkins Center for Psychedelic and Consciousness Research symbolizes his lasting impact.

Cite This Study

Henningfield et al. (2026) studied this question.

synapsesocial.com/papers/69be37956e48c4981c67751ahttps://doi.org/10.1177/02698811251398801
View Full Paper
Ask AI
Bookmark
Share